In This Article:
As global markets face economic uncertainties and stock indices experience significant declines, the Swedish market remains a focal point for investors seeking resilient growth opportunities. In this environment, companies with high insider ownership often signal strong confidence from those who know the business best, making them attractive candidates for long-term growth investments.
Top 10 Growth Companies With High Insider Ownership In Sweden
Name | Insider Ownership | Earnings Growth |
CTT Systems (OM:CTT) | 16.9% | 24.8% |
Truecaller (OM:TRUE B) | 29.5% | 21.6% |
Fortnox (OM:FNOX) | 21.1% | 22.6% |
Magle Chemoswed Holding (OM:MAGLE) | 14.9% | 72.2% |
Biovica International (OM:BIOVIC B) | 18.8% | 73.1% |
BioArctic (OM:BIOA B) | 34% | 98.4% |
Yubico (OM:YUBICO) | 37.5% | 42.5% |
KebNi (OM:KEBNI B) | 37.8% | 86.1% |
InCoax Networks (OM:INCOAX) | 19.3% | 115.5% |
C-Rad (OM:CRAD B) | 16.1% | 33.9% |
We're going to check out a few of the best picks from our screener tool.
BioArctic
Simply Wall St Growth Rating: ★★★★★★
Overview: BioArctic AB (publ) develops biological drugs for central nervous system disorders in Sweden and has a market cap of SEK 16.08 billion.
Operations: BioArctic AB (publ) generates revenue primarily from its biotechnology segment, amounting to SEK 299.35 million.
Insider Ownership: 34%
Return On Equity Forecast: 28% (2027 estimate)
BioArctic, a Swedish biotech firm, showcases significant growth potential with high insider ownership. The company is forecast to achieve profitability within three years and expects annual revenue growth of 42.4%, outpacing the market. Recent earnings reveal substantial sales increases despite ongoing net losses. Key product developments include promising Phase 1 results for exidavnemab and multiple global approvals for Leqembi?, an Alzheimer's treatment, highlighting BioArctic's innovative capabilities in neurodegenerative diseases.
-
Take a closer look at BioArctic's potential here in our earnings growth report.
-
Our expertly prepared valuation report BioArctic implies its share price may be lower than expected.
CTT Systems
Simply Wall St Growth Rating: ★★★★★★
Overview: CTT Systems AB (publ) designs, manufactures, and sells humidity control systems for aircraft in Sweden, Denmark, France, the United States, and internationally with a market cap of SEK 3.40 billion.
Operations: The company's revenue segment primarily comes from Aerospace & Defense, amounting to SEK 317.70 million.
Insider Ownership: 16.9%
Return On Equity Forecast: 44% (2027 estimate)